SCHEMBL7909446

SCHEMBL7909446

N=C(N)N1CCN(CCC(=O)Nc2cccc(C(=O)NCCC(=O)O)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.49
EPHX2 P34913 1/20 0.48
GAA P10253 1/20 0.47
PKM P14618 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 2/20 0.46
ITGB3 P05106 2/20 0.46
ITGA2B P08514 1/20 0.46
POLB P06746 2/20 0.45
MAPT P10636 1/20 0.45
ITGA2 P17301 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7900164 0.91 MEN1 (0.50) SMN1; SMN2EPHX2GAAALDH1A1ITGB3
SCHEMBL8380945 0.91 SMN1; SMN2 (0.50) SMN1; SMN2EPHX2PKML3MBTL1ALDH1A1
SCHEMBL7913458 0.90 SMN1; SMN2 (0.52) SMN1; SMN2EPHX2GAAPKML3MBTL1
SCHEMBL7909721 0.87 POLB (0.46) EPHX2GAAITGB3ITGA2BPOLB
SCHEMBL8381010 0.87 SMN1; SMN2 (0.55) SMN1; SMN2PKML3MBTL1ALDH1A1POLB
SCHEMBL7907928 0.86 GAA (0.45) SMN1; SMN2EPHX2GAAL3MBTL1ITGB3
SCHEMBL8381648 0.85 EPHX2 (0.49) SMN1; SMN2EPHX2GAAALDH1A1ITGB3
SCHEMBL8381940 0.85 SMN1; SMN2 (0.52) SMN1; SMN2PKML3MBTL1ALDH1A1POLB
SCHEMBL9335780 0.85 ITGB3 (0.50) SMN1; SMN2GAAALDH1A1ITGB3ITGA2B
SCHEMBL7909440 0.84 ITGB3 (0.54) SMN1; SMN2EPHX2GAAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0608759-B1 Piperazine derivatives MERCK PATENT GMBH (DE) 2001-08-22 EP disclosed
US-5908843-A Piperazine compounds as fibrinogen inhibitors MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-06-01 US disclosed
EP-0608759-A2 Piperazinderivatives MERCK PATENT GmbH (DE) 1994-08-03 EP disclosed